4-(4-{4-[(4-methylphenyl)methyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}piperidine-1-carbonyl)benzonitrile

Catalog No. :
ACUVLH512
CAS No. :
1775548-72-5
Molecular Formula :
C23H23N5O2
Molecular Weight :
401.47

IUPAC Name:4-(4-(4-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)piperidine-1-carbonyl)benzonitrile

4-(4-{4-[(4-methylphenyl)methyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}piperidine-1-carbonyl)benzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$214.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-{4-[(4-methylphenyl)methyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}piperidine-1-carbonyl)benzonitrile
IUPAC Name4-(4-(4-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)piperidine-1-carbonyl)benzonitrile
MDL No.MFCD28976258
Molecular FormulaC23H23N5O2
Molecular Weight401.47
SMILESN#CC1=CC=C(C(N2CCC(C(N3CC4=CC=C(C)C=C4)=NNC3=O)CC2)=O)C=C1
InChI KeyLYFVOYNFUPUFRI-UHFFFAOYSA-N
Synonym4-(4-{4-[(4-methylphenyl)methyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl}piperidine-1-carbonyl)benzonitrile;Benzonitrile, 4-[[4-[4,5-dihydro-4-[(4-methylphenyl)methyl]-5-oxo-1H-1,2,4-triazol-3-yl]-1-piperidinyl]carbonyl]-
CAS No.1775548-72-5

Synthetic Route by SureRoute

1. ACUVLH512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUVLH512 route product structure diagram
    ACUVLH5121775548-72-5
Inquiry

2. ACUVLH512 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDSML693 route compound structure diagram
    ACDSML6936068-72-0 In Stock
  4. Then
  5. ACUVLH512 route product structure diagram
    ACUVLH5121775548-72-5
Inquiry

Comments (0)